Storage and handling
Other Information: Protect the production this container from excessive heat and direct sun.
No Foundation Foundation No.2 Light to Medium
- Manufacturer
- Allure Labs, Inc.
- Effective date
- 2014-04-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:39:11
Label at a glance#
ProductNo Foundation Foundation No.2 Light to Medium
Active ingredientZINC OXIDE, TITANIUM DIOXIDE
Label structure10 sections
Contacts and useful links#
Websitewww.perriconemd.com
www.perriconemd.com
www.perriconemd.comLabel contents#
Full prescribing information#
OTC - PURPOSE SECTION
PURPOSE:
Sunscreen
INDICATIONS & USAGE SECTION
USES:
Helps prevent sunburn
If used as directed with other sun protection measures (see directions) decreases the chance of skin cancer and early skin aging caused by the sun.
WARNINGS SECTION
WARNINGS:
- For external use only
OTC - WHEN USING SECTION
WHEN USING THIS PRODUCT:
- Keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
STOP USE AND ASK A DOCTOR IF
- Rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN
If swallowed, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
DIRECTIONS:
- Dr. Perricone recommends applying evenly with your fingertips and blending product in circular motions. Can be re-applied as necessary to build desired coverage.
- use liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least evry 2 hours
- Not for use on children.
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease the risk, regularly use a sunscreen with a Broad Spectrun SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10:00am -2pm.
- wear long-sleeved shirts, pants, hats and sunglasses.
STORAGE AND HANDLING SECTION
Other Information:
- Protect the production this container from excessive heat and direct sun.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS:
Aqua (Water), Cyclopentasiloxane, Butylene Glycol, Glycerin, Glyceryl Stearate, PEG-100 Stearate, Tetrahexyldecyl Ascorbate, C12-15 Alkyl Benzoate, Polyglyceryl-3 Polydimethylsiloxyethyl Dimethicone,Dimethicone, Sorbitan Stearate, Caprylic/Capric Triglyceride, Ethylhexyl Palmitate, Cyclohexasiloxane, Iron Oxides (CI77492, CI77491, CI77499), Aluminum Hydroxide, Stearic AcidGlycolic Acid, Dimethyl MEA (DMAE), Mica, Phenoxyethanol, Citric Acid, Tribehenin, Caprylyl Glycol, Lecithin, Cetyl Alcohol, Tocopheryl Linoleate/Oleate, Thioctic Acid (Alpha-Lipoic Acid), Hexylene Glycol, Ethylhexylglycerin, Xanthan Gum, PEG-8, Triethoxysilylethyl Polydimethylsilxyethyl Hexyl Dimethicone, Polyacrylamide, Citrus Medica Limonum (Lemon) Peel Oil, Limonene, Sodium Lactate, Ceramide-2, Aluminum Hydroxide,C13-14 Isoparaffin, PEG-10 Rapeseed Sterol, Disodium EDTA, Dipotassium Glycyrrhizate, Tocopherol, Phoenix Dactylifera (Date) Fruit Extract, Silica Dimethyl Silylate, Teprenone, Triethoxycaprylylsilane, Linalool, Laureth-7, Silica, Ascorbyl Palmitate, Hyaluronic Acid, Ascorbic Acid, Arabidopsis Thaliana Extract, Plankton Extract, Micrococcus Lysate, Palmitoyl Oligopeptide, Salvia Sclarea (Clary) Extract, Cedrus Atlantica Bark Oil, Ilex Paraguariensis Leaf Extract, Bulnesia SarmientoiWood Oil, Coriandrm Sativum (Coriander) Fruit Oil, Salvia Sclarea (Clary) Oil, Eugenia Caryophyllus (Clove) Flower Oil, Triticum Vulgare (Wheat) Bran Extract, Anthemis Nobilis Flower Oil, Jasminum Officinale (Jasmine) Oil, Viola Odorata Flower/Leaf Extract.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DISTRIBUTOR (US):
NV Perricone LLC,
Meriden CT 06450.
DISTRIBUTOR (UK):
NV Perricone MD Cosmeceuticals LTD
London, W1T 3LN UK
1 888 823 7837
IMAGE OF THE PRODUCT:
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62742-4066-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3f93-60a7-e053-dbdaa90a05bd | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62742-4066-1 | No Foundation Foundation No.2 Light to Medium | 30 mL in 1 BOTTLE, PUMP | CREAM | 30 | 1 | |
| 62742-4066-2 | No Foundation Foundation No.2 Light to Medium | 1 in 1 CARTON | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62742-4066 | NO FOUNDATION FOUNDATION NO.2 LIGHT TO MEDIUM (ZINC OXIDE AND TITANIUM DIOXIDE) CREAM [ALLURE LABS, INC.] | 1 | Legacy NDC, 2 package rows | 20140506_0945dce7-2c45-4769-958a-02bd68568ecb.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| 2-(DIETHYLAMINO)ETHANOL | INACTIVE INGREDIENT | S6DL4M053U | 1 | |
| ACRYLAMIDE | INACTIVE INGREDIENT | 20R035KLCI | 1 | |
| ALPHA LIPOIC ACID | INACTIVE INGREDIENT | 73Y7P0K73Y | 1 | |
| ALPHA-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 1 | |
| ALPHA-TOCOPHEROL, D- | INACTIVE INGREDIENT | N9PR3490H9 | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| ASCORBIC ACID | INACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| ASCORBYL PALMITATE | INACTIVE INGREDIENT | QN83US2B0N | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| C12-15 ALKYL BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| C13-14 ISOPARAFFIN | INACTIVE INGREDIENT | E4F12ROE70 | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CHAMAEMELUM NOBILE FLOWER | INACTIVE INGREDIENT | O2T154T6OG | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| CLARY SAGE | INACTIVE INGREDIENT | U3HSK5JC0Q | 1 | |
| CLOVE OIL | INACTIVE INGREDIENT | 578389D6D0 | 1 | |
| CORIANDER OIL | INACTIVE INGREDIENT | 7626GC95E5 | 1 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DATE | INACTIVE INGREDIENT | H3O7QI5HY7 | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| ETHYLHEXYL PALMITATE | INACTIVE INGREDIENT | 2865993309 | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| GLYCOLIC ACID | INACTIVE INGREDIENT | 0WT12SX38S | 1 | |
| GLYCYRRHIZINATE DIPOTASSIUM | INACTIVE INGREDIENT | CA2Y0FE3FX | 1 | |
| GUAIAC OIL | INACTIVE INGREDIENT | 81H0L6W02F | 1 | |
| HEXYLENE GLYCOL | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| HYALURONIC ACID | INACTIVE INGREDIENT | S270N0TRQY | 1 | |
| ILEX PARAGUARIENSIS LEAF | INACTIVE INGREDIENT | 1Q953B4O4F | 1 | |
| JASMINUM OFFICINALE FLOWER | INACTIVE INGREDIENT | 0Q8K841432 | 1 | |
| LAURETH-7 | INACTIVE INGREDIENT | Z95S6G8201 | 1 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| LEMON OIL | INACTIVE INGREDIENT | I9GRO824LL | 1 | |
| LIMONENE, (+)- | INACTIVE INGREDIENT | GFD7C86Q1W | 1 | |
| LINALOOL, D- | INACTIVE INGREDIENT | F4VNO44C09 | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | 1 | |
| POLYOXYL 100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM LACTATE | INACTIVE INGREDIENT | TU7HW0W0QT | 1 | |
| SORBITAN MONOSTEARATE | INACTIVE INGREDIENT | NVZ4I0H58X | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| TEPRENONE | INACTIVE INGREDIENT | S8S8451A4O | 1 | |
| TETRAHEXYLDECYL ASCORBATE | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| VIOLA ODORATA | INACTIVE INGREDIENT | AET12U8B74 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| WHEAT BRAN | INACTIVE INGREDIENT | 6L966A1IMR | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- No Foundation Foundation No.2 Light to Medium
- Zinc Oxide and Titanium Dioxide
- ZINC OXIDE
- TITANIUM DIOXIDE
- WATER
- CYCLOMETHICONE 5
- BUTYLENE GLYCOL
- GLYCERIN
- GLYCERYL MONOSTEARATE
- POLYOXYL 100 STEARATE
- TETRAHEXYLDECYL ASCORBATE
- C12-15 ALKYL BENZOATE
- SORBITAN MONOSTEARATE
- MEDIUM-CHAIN TRIGLYCERIDES
- ETHYLHEXYL PALMITATE
- CYCLOMETHICONE 6
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- GLYCOLIC ACID
- 2-(DIETHYLAMINO)ETHANOL
- MICA
- PHENOXYETHANOL
- CITRIC ACID MONOHYDRATE
- TRIBEHENIN
- CAPRYLYL GLYCOL
- LECITHIN, SOYBEAN
- CETYL ALCOHOL
- ALPHA-TOCOPHEROL, D-
- ALPHA LIPOIC ACID
- DIMETHICONE
- HEXYLENE GLYCOL
- ETHYLHEXYLGLYCERIN
- XANTHAN GUM
- POLYETHYLENE GLYCOL 400
- CYCLOMETHICONE
- ACRYLAMIDE
- LEMON OIL
- LIMONENE, (+)-
- SODIUM LACTATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62742-4066 | 62742-4066-1, 62742-4066-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET / ORAL | 2 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | OINTMENT / TOPICAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY / NASAL | 1 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | OINTMENT / TOPICAL | NA | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SOLUTION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / BUCCAL | 1 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, COATED / ORAL | 0.01 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | POWDER, FOR SUSPENSION / ORAL | 285 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| ASCORBYL PALMITATE | ASCORBYL PALMITATE | QN83US2B0N | SUPPOSITORY / RECTAL | 16 mg | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / ORAL | 62.5 mg/5ml | ||
| LIMONENE, (+)- | LIMONENE, (+)- | GFD7C86Q1W | LOTION / TOPICAL | 10 %v/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | GEL / TOPICAL | 280 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION / ORAL | 450 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / VAGINAL | 0.75 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SUBCUTANEOUS | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | CAPSULE, DELAYED RELEASE / ORAL | 26 mg | ||
| LIMONENE, (+)- | LIMONENE, (+)- | GFD7C86Q1W | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO, SUSPENSION / TOPICAL | 1 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET / ORAL | 100 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SUSPENSION / ORAL | 20 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2032c3e0-9ada-4654-a245-53577d1243ef | 0945dce7-2c45-4769-958a-02bd68568ecb | 2014-04-14 | Warnings | 2032c3e0-9ada-4654-a245-53577d1243ef 0945dce7-2c45-4769-958a-02bd68568ecb |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.